Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Refresh Optive Advanced in Dry Eye Disease
NCT01459588Phase 3Completed
- Sponsor
- Allergan
- Start
- Oct 2011
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Optive Advanced in dry eye syndrome (DED), sponsored by Allergan. Started Oct 2011; status: completed.
02
Drugs
Optive Advanced
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT01459588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01459588.